Determinants of Quality of Life in Patients With Intestinal Failure Receiving Long-Term Parenteral Nutrition Using the SF-36 Questionnaire: A German Single-Center Prospective Observational Study.
SF-36
intestinal failure
parenteral nutrition
quality of life
Journal
JPEN. Journal of parenteral and enteral nutrition
ISSN: 1941-2444
Titre abrégé: JPEN J Parenter Enteral Nutr
Pays: United States
ID NLM: 7804134
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
14
12
2018
accepted:
19
02
2019
pubmed:
14
3
2019
medline:
9
2
2021
entrez:
14
3
2019
Statut:
ppublish
Résumé
Parenteral nutrition (PN) is a life-sustaining therapy for patients with chronic intestinal failure (IF) but inevitably has an impact on patients' quality of life (QoL). The purpose of this study was to examine multiple aspects of QoL by utilizing the standardized Short Form 36 (SF-36) health survey. Between 2014 and 2017, a total of 90 adult patients with IF who were receiving PN were prospectively enrolled in an observational study. All subjects underwent nutrition status assessment, liver assessment, blood tests, and QoL assessment based on the SF-36. Univariate and multivariable analyses were performed to identify determinants of 8 domains and 2 summary scales of the SF-36. Analysis of the SF-36 questionnaire data showed that QoL was significantly worse compared with the general German population across all categories. Multivariable analysis revealed that bioelectrical impedance analysis of phase angle (1/10 categories), stoma/fistula (4/10 categories), oral intake (4/10 categories), infusions per week (1/10 categories), duration of PN (1/10 categories), citrulline (4/10 categories), and hemoglobin levels (1/10 categories) are independent risk factors affecting QoL. This study uses the largest cohort of IF patients assessed by the standardized SF-36 questionnaire to comprehensively analyze QoL. Presence of oral intake, presence of ostomy, and citrulline levels were independently correlated with 4 of 10 categories of the SF-36. These results indicate that to improve QoL for IF patients, clinical care should focus on addressing the social and emotional value of oral intake, educational interventions, early stoma closure, and application of new targeted therapies.
Sections du résumé
BACKGROUND
Parenteral nutrition (PN) is a life-sustaining therapy for patients with chronic intestinal failure (IF) but inevitably has an impact on patients' quality of life (QoL). The purpose of this study was to examine multiple aspects of QoL by utilizing the standardized Short Form 36 (SF-36) health survey.
METHODS
Between 2014 and 2017, a total of 90 adult patients with IF who were receiving PN were prospectively enrolled in an observational study. All subjects underwent nutrition status assessment, liver assessment, blood tests, and QoL assessment based on the SF-36. Univariate and multivariable analyses were performed to identify determinants of 8 domains and 2 summary scales of the SF-36.
RESULTS
Analysis of the SF-36 questionnaire data showed that QoL was significantly worse compared with the general German population across all categories. Multivariable analysis revealed that bioelectrical impedance analysis of phase angle (1/10 categories), stoma/fistula (4/10 categories), oral intake (4/10 categories), infusions per week (1/10 categories), duration of PN (1/10 categories), citrulline (4/10 categories), and hemoglobin levels (1/10 categories) are independent risk factors affecting QoL.
CONCLUSION
This study uses the largest cohort of IF patients assessed by the standardized SF-36 questionnaire to comprehensively analyze QoL. Presence of oral intake, presence of ostomy, and citrulline levels were independently correlated with 4 of 10 categories of the SF-36. These results indicate that to improve QoL for IF patients, clinical care should focus on addressing the social and emotional value of oral intake, educational interventions, early stoma closure, and application of new targeted therapies.
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
291-300Informations de copyright
© 2019 American Society for Parenteral and Enteral Nutrition.
Références
Pironi L, Arends J, Bozzetti F, et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35:247-307.
Dibb M, Teubner A, Theis V, Shaffer J, Lal S. Review article: the management of long-term parenteral nutrition. Aliment Pharmacol Ther. 2013;37:587-603.
Bozzetti F, Mariani L, Bertinet DB, et al. Central venous catheter complications in 447 patients on home parenteral nutrition: an analysis of over 100,000 catheter days. Clin Nutr. 2002;21:475-485.
Messing B, Crenn P, Beau P, Boutron-Ruault MC, Rambaud JC, Matuchansky C. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology. 1999;117:1043-1050.
Pironi L, Paganelli F, Labate AMM, et al. Safety and efficacy of home parenteral nutrition for chronic intestinal failure: a 16-year experience at a single centre. Dig Liver Dis. 2003;35:314-324.
Pevny S, Maasberg S, Rieger A, et al. Experience with teduglutide treatment for short bowel syndrome in clinical practice [Epub ahead of print]. Clin Nutr. 2018. https://doi.org/10.1016/j.clnu.2018.07.030.
Reddy P, Malone M. Cost and outcome analysis of home parenteral and enteral nutrition. JPEN J Parenter Enter Nutr. 1998;22:302-310.
Jeppesen PB, Langholz E, Mortensen PB. Quality of life in patients receiving home parenteral nutrition. Gut. 1999;44:844-852.
Richards DM, Irving MH. Assessing the quality of life of patients with intestinal failure on home parenteral nutrition. Gut. 1997;40:218-222.
Jamieson CP, Norton B, Day T, Lakeman M, Powell-Tuck J. The quantitative effect of nutrition support on quality of life in outpatients. Clin Nutr. 1997;16:25-28.
Scoggins JF, Patrick DL. The use of patient-reported outcomes instruments in registered clinical trials: evidence from ClinicalTrials.gov. Contemp Clin Trials. 2009;30:289-292.
Gandek B, Sinclair SJ, Kosinski M, Ware JE. Psychometric evaluation of the SF-36 health survey in Medicare managed care. Health Care Financ Rev. 2004;25:5-25.
Pironi L, Paganelli F, Mosconi P, et al. The SF-36 instrument for the follow-up of health-related quality-of-life assessment of patients undergoing home parenteral nutrition for benign disease. Transplant Proc. 2004;36:255-258.
von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12:1495-1499.
Stockmann M, Lock JF, Riecke B, et al. Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg. 2009;250:119-125.
Jara M, Bednarsch J, Valle E, et al. Reliable assessment of liver function using LiMAx. J Surg Res. 2015;193:184-189.
Stehr A, Ploner F, Traeger K, et al. Plasma disappearance of indocyanine green: a marker for excretory liver function? Intensive Care Med. 2005;31:1719-1722.
Sakka SG. Assessing liver function. Curr Opin Crit Care. 2007;13:207-214.
Sandrin L, Fourquet B, Hasquenoph J-M, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705-1713.
Rombeau JL, Bandini L BR. Bioelectrical impedance analysis in body composition measurement: National Institutes of Health Technology Assessment Conference statement. Am J Clin Nutr. 1996;64:524S-532S.
Matarese LE. Indirect calorimetry: technical aspects. J Am Diet Assoc. 1997;97:S154-S160.
Raszeja-Wyszomirska J, Kucharski R, Zygmunt M, Safranow K, Miazgowski T. The impact of fragility fractures on health-related quality of life in patients with primary sclerosing cholangitis. Hepat Mon. 2015;15:e25539. https://doi.org/10.5812/hepatmon.25539.
McHorney CA, Ware JE, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32:40-66.
Ellert U, Bellach BM. [The SF-36 in the Federal Health Survey-description of a current normal sample]. Gesundheitswesen. 1999;61 Spec No:S184-90.
Huisman-de Waal G, Schoonhoven L, Jansen J, Wanten G, van Achterberg T. The impact of home parenteral nutrition on daily life-a review. Clin Nutr. 2007;26:275-288.
Jeppesen PB, Pertkiewicz M, Forbes A, et al. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide-analyses from a randomised, placebo-controlled study. Clin Nutr. 2013;32:713-721.
Berghofer P, Fragkos KC, Baxter JP, et al. Development and validation of the disease-specific short bowel syndrome-quality of life (SBS-QoL) scale. Clin Nutr. 2013;32:789-796.
Baxter JP, Fayers PM, Bozzetti F, et al. An international study of the quality of life of adult patients treated with home parenteral nutrition [Epub ahead of print]. Clin Nutr. 2018. https://doi.org/10.1016/j.clnu.2018.07.024.
Ablett J, Vasant DH, Taylor M, Cawley C, Lal S. Poor social support and unemployment are associated with negative affect in home parenteral nutrition-dependent patients with chronic intestinal failure. J Parenter Enter Nutr. 2019;43:534-539.
Richards DM, Scott NA, Shaffer JL, Irving M. Opiate and sedative dependence predicts a poor outcome for patients receiving home parenteral nutrition. JPEN J Parenter Enter Nutr. 1997;21:336-338.
Malone M. Longitudinal assessment of outcome, health status, and changes in lifestyle associated with long-term home parenteral and enteral nutrition. JPEN J Parenter Enter Nutr. 2002;26:164-168.
Cameron EAB, Binnie JAH, Jamieson N V, Pollard S, Middleton SJ. Quality of life in adults following small bowel transplantation. Transplant Proc. 2002;34:965-966.
Carlsson E, Bosaeus I, Nordgren S. Quality of life and concerns in patients with short bowel syndrome. Clin Nutr. 2003;22:445-452.
Pironi L, Paganelli F, Lauro A, Spinucci G, Guidetti M, Pinna AD. Quality of life on home parenteral nutrition or after intestinal transplantation. Transplant Proc. 2006;38:1673-1675.
Ławiński M, Kot-Mielczarska E, Gradowska A. Quality of life of patients on chronic parenteral nutrition before and after gastrointestinal tract continuity restoration. Polish J Surg. 2015;87:153-159.
Wilburn J, McKenna SP, Heaney A, et al. Development and validation of the Parenteral Nutrition Impact Questionnaire (PNIQ), a patient-centric outcome measure for home parenteral nutrition. Clin Nutr. 2018;37:978-983.
Heaney A, McKenna SP, Wilburn J, et al. The impact of home parenteral nutrition on the lives of adults with type 3 intestinal failure. Clin Nutr ESPEN. 2018;24:35-40.
Winkler MF, Hagan E, Wetle T, Smith C, Maillet JO, Touger-Decker R. An exploration of quality of life and the experience of living with home parenteral nutrition. J Parenter Enter Nutr. 2010;34:395-407.
Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology. 2000;119:1496-1505.
Barr JT, Schumacher GE. The need for a nutrition-related quality-of-life measure. J Am Diet Assoc. 2003;103:177-180.
Winkler MF, Wetle T, Smith C, Hagan E, O'Sullivan Maillet J, Touger-Decker R. The meaning of food and eating among home parenteral nutrition-dependent adults with intestinal failure: a qualitative inquiry. J Am Diet Assoc. 2010;110:1676-1683.
Carlsson E, Berglund B, Nordgren S. Living with an ostomy and short bowel syndrome: practical aspects and impact on daily life. J WOCN. 2001;28:96-105.
Danielsen AK, Burcharth J, Rosenberg J. Patient education has a positive effect in patients with a stoma: a systematic review. Color Dis. 2013;15:e276-283.
Winkler MF, Hagan E, Wetle T, Smith C, O'Sullivan Maillet J, Touger-Decker R. An exploration of quality of life and the experience of living with home parenteral nutrition. J Parenter Enter Nutr. 2010;34:395-407.